Distribution of systemically administered nanoparticles reveals a size-dependent effect immediately following cardiac ischaemia-reperfusion injury

David J. Lundy, Kun Hung Chen, Elsie K.W. Toh, Patrick C.H. Hsieh

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Nanoparticles represent an attractive option for systemic delivery of therapeutic compounds to the heart following myocardial infarction. However, it is well known that physicochemical properties of nanoparticles such as size, shape and surface modifications can vastly alter the distribution and uptake of injected nanoparticles. Therefore, we aimed to provide an examination of the rapid size-dependent uptake of fluorescent PEG-modified polystyrene nanoparticles administered immediately following cardiac ischaemia-reperfusion injury in mice. By assessing the biodistribution of nanoparticles with core diameters between 20 nm and 2 - 1/4m 30 minutes after their administration, we conclude that 20-200 nm diameter nanoparticles are optimal for passive targeting of the injured left ventricle.

Original languageEnglish
Article number25613
JournalScientific Reports
Volume6
DOIs
Publication statusPublished - May 10 2016
Externally publishedYes

Fingerprint

Reperfusion Injury
Nanoparticles
Polystyrenes
Heart Ventricles
Myocardial Infarction

ASJC Scopus subject areas

  • General

Cite this

Distribution of systemically administered nanoparticles reveals a size-dependent effect immediately following cardiac ischaemia-reperfusion injury. / Lundy, David J.; Chen, Kun Hung; Toh, Elsie K.W.; Hsieh, Patrick C.H.

In: Scientific Reports, Vol. 6, 25613, 10.05.2016.

Research output: Contribution to journalArticle

@article{311a7d705bb044eb8849b4e3f310cd5c,
title = "Distribution of systemically administered nanoparticles reveals a size-dependent effect immediately following cardiac ischaemia-reperfusion injury",
abstract = "Nanoparticles represent an attractive option for systemic delivery of therapeutic compounds to the heart following myocardial infarction. However, it is well known that physicochemical properties of nanoparticles such as size, shape and surface modifications can vastly alter the distribution and uptake of injected nanoparticles. Therefore, we aimed to provide an examination of the rapid size-dependent uptake of fluorescent PEG-modified polystyrene nanoparticles administered immediately following cardiac ischaemia-reperfusion injury in mice. By assessing the biodistribution of nanoparticles with core diameters between 20 nm and 2 - 1/4m 30 minutes after their administration, we conclude that 20-200 nm diameter nanoparticles are optimal for passive targeting of the injured left ventricle.",
author = "Lundy, {David J.} and Chen, {Kun Hung} and Toh, {Elsie K.W.} and Hsieh, {Patrick C.H.}",
year = "2016",
month = "5",
day = "10",
doi = "10.1038/srep25613",
language = "English",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Distribution of systemically administered nanoparticles reveals a size-dependent effect immediately following cardiac ischaemia-reperfusion injury

AU - Lundy, David J.

AU - Chen, Kun Hung

AU - Toh, Elsie K.W.

AU - Hsieh, Patrick C.H.

PY - 2016/5/10

Y1 - 2016/5/10

N2 - Nanoparticles represent an attractive option for systemic delivery of therapeutic compounds to the heart following myocardial infarction. However, it is well known that physicochemical properties of nanoparticles such as size, shape and surface modifications can vastly alter the distribution and uptake of injected nanoparticles. Therefore, we aimed to provide an examination of the rapid size-dependent uptake of fluorescent PEG-modified polystyrene nanoparticles administered immediately following cardiac ischaemia-reperfusion injury in mice. By assessing the biodistribution of nanoparticles with core diameters between 20 nm and 2 - 1/4m 30 minutes after their administration, we conclude that 20-200 nm diameter nanoparticles are optimal for passive targeting of the injured left ventricle.

AB - Nanoparticles represent an attractive option for systemic delivery of therapeutic compounds to the heart following myocardial infarction. However, it is well known that physicochemical properties of nanoparticles such as size, shape and surface modifications can vastly alter the distribution and uptake of injected nanoparticles. Therefore, we aimed to provide an examination of the rapid size-dependent uptake of fluorescent PEG-modified polystyrene nanoparticles administered immediately following cardiac ischaemia-reperfusion injury in mice. By assessing the biodistribution of nanoparticles with core diameters between 20 nm and 2 - 1/4m 30 minutes after their administration, we conclude that 20-200 nm diameter nanoparticles are optimal for passive targeting of the injured left ventricle.

UR - http://www.scopus.com/inward/record.url?scp=84966705302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966705302&partnerID=8YFLogxK

U2 - 10.1038/srep25613

DO - 10.1038/srep25613

M3 - Article

C2 - 27161857

AN - SCOPUS:84966705302

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 25613

ER -